Pediatric Device Consortium

UCSF-Stanford Pediatric Device Consortium

Each year, far fewer heath technologies are approved by the US Food & Drug Administration for children than adults. This means pediatric specialists do not always have access to the advanced tools they need to address the unique healthcare needs of their small, vulnerable patients.

Pediatric Device Consortium

In 2018, UCSF and Stanford teamed up to launch the UCSF-Stanford Pediatric Device Consortium (PDC) with the mission to improve the health, safety, and quality of life of pediatric patients by accelerating the development and availability of high-value, high-impact pediatric health technology solutions.

The PDC, which is funded by the US FDA, leverages Stanford Biodesign’s need-driven innovation process to accomplish its goals. It benefits from access to world-leading clinical and engineering technical experts at UCSF and Stanford, as well as an unparalleled network of Silicon Valley experts in medical device product development, regulatory affairs, intellectual property, reimbursement, and commercialization.

Learn more on the PDC website and subscribe to the PDC mailing list.